NEW YORK (GenomeWeb News) – Becton Dickinson today reported that revenues for its fiscal third quarter increased almost 4 percent year over year.

The company recorded $2.05 billion in revenues for the three months ended June 30, up from $1.98 billion during the third quarter of Fiscal Year 2012 and matching the average Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.